Y-Biologics, Inc. (KOSDAQ:338840)
7,670.00
-540.00 (-6.58%)
At close: Nov 20, 2026
Y-Biologics Market Cap
Y-Biologics has a market cap or net worth of 117.86 billion as of November 20, 2026. It is the 25,465th most valuable company in the world and the 1,072nd biggest in South Korea. Its market cap has decreased by 66.02% in one year.
Market Cap
117.86B
Enterprise Value
95.84B
Revenue
3.17B
Global Rank
Country Rank
#1,072 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 5, 2023, Y-Biologics's market cap has decreased from 177.50B to 117.86B, a decrease of -33.60%. That is a compound annual growth rate of -12.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 117.86B | -66.09% |
| Dec 30, 2025 | 347.58B | 205.76% |
| Dec 30, 2024 | 113.68B | -50.64% |
| Dec 28, 2023 | 230.30B | 29.75% |
| Dec 5, 2023 | 177.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kangstem Biotech | 165.35B |
| AriBioLab | 163.04B |
| curacle co.,ltd. | 159.53B |
| Genome & Company | 148.79B |
| NIBEC | 147.89B |
| ISU Abxis | 126.20B |
| Bio Solution | 119.86B |
| Kanaph Therapeutics | 111.86B |